HLB제넥스

187420KOSDAQ기초 의약물질 제조업

54.8 / 100

Reference Date: 2026-06-10

Financial Score21.5 / 40

News Sentiment21.3 / 25

Momentum2.0 / 20

Disclosure10.0 / 15

AI Analysis: PER is significantly undervalued vs. peers but the high debt ratio poses financial risk. Plunged 19.6% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

HLB제넥스 is a biotech company founded in 2000, specializing in the development and production of customized enzymes and bio-healthcare materials using core technologies like microbial display and recombinant protein secretion. Its main business areas include industrial specialty enzymes, bio-healthcare materials, and microbiome-enzyme products, with key offerings such as eco-friendly catalase, lactase for GOS production, and nattokinase for cardiovascular health. The company is also advancing its pipeline drug GF103, an oral treatment for wet age-related macular degeneration, currently preparing for Phase I clinical trials.

Number of Employees

82people

Average Salary

57.5M KRW

Score Calculation Basis

Detailed Financial Score

PER

2.84Industry Average 27.718.0Point

Half of industry avg (excellent)

PBR

1.31Industry Average 1.744.0Point

In line with industry avg

ROE

55.20Industry Average -6.033.5Point

Well below industry avg

Debt Ratio

33.29Industry Average 6.620.0Point

5.0x industry avg (risky)

Trend 2023~20256.0 / 10 points

Revenue Growth Rate

3.0 / 3

Avg ▲26.8% (2-year basis)

Operating Profit Growth Rate

3.0 / 3

Avg ▲122.2% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -4.4% (improving, 3yr)

Detailed News Sentiment

4 totalPositive 4Neutral 0Negative 0Average Sentiment Score 85

Positive
HLB제넥스, 반도체용 '카탈라아제' 미국 공급 개시
HLB제넥스의 미국 반도체 공정용 카탈라아제 공급 개시로 글로벌 시장 진출 성공 기대.
Positive
박홍근 "내년도 예산서 R&D 투자 확대…기술구조 성장 뒷받침"
예산서를 통한 R&D 투자 확대 계획 발표로 HLB제넥스의 기술 성장 지원 기대감 증가.
Positive
HLB제넥스, 1분기 영업익 10억…전년比 25%↑
HLB제넥스의 1분기 영업이익이 전년 대비 25% 증가하며 수익성 향상을 보여주었다.

Detailed Momentum

52-week position1.0Point

Near 52w low (5%, downtrend)

Current 2,200Won52-week high 3,53552-week low 2,120

1-month return0.0Point

1m -19.56% (strong drop)

Volume trend1.0Point

Volume decreasing

Detailed Disclosure

6 totalPositive 0Neutral 6Negative 0

Neutral주식등의대량보유상황보고서(일반)2026-06-09
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-06-05
Neutral주식등의대량보유상황보고서(일반)2026-06-02
Neutral주식등의대량보유상황보고서(일반)2026-05-26
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-05-20